中国冶金工业医学杂志

2型糖尿病合并非酒精性脂肪性肝病患者的代谢情况分析

作者：骆秀婷1 林克宣2

分类号：R 587.1

出版年,卷(期):页码：2020,37(6):621-622

摘要：

摘要：目的了解2型糖尿病合并非酒精性脂肪性肝病（NAFLD）患者的代谢情况。方法将2型糖尿病合并NAFLD患者579例按NAFLD程度分为A组（轻度）、B组（中度）、C组（重度），比较并分析3组患者的BMI、尿酸、糖化血红蛋白、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇水平。结果 3组间BMI、总胆固醇、甘油三酯、尿酸、糖化血红蛋白比较，差异有统计学意义（P＜0.05）。其中，B、C组BMI、尿酸较A组有明显升高；C组总胆固醇、甘油三酯较A、B组有明显升高；B组糖化血红蛋白水平最高；3组低密度脂蛋白胆固醇和高密度脂蛋白胆固醇组间差异无统计学意义（P＞0.05）。结论 BMI、总胆固醇、甘油三酯、尿酸与2型糖尿病合并非酒精性脂肪性肝病程度具有相关性，临床应尽早进行危险因素筛查及防控。

Abstract：Objective To investigate the metabolic status of type 2 diabetes mellitus with nonalcoholic fatty liver disease（NAFLD）. Methods 579 patients with type 2 diabetes mellitus complicated with NAFLD were divided into group A（mild），group B (moderate)，and group C (severe) according to the degree of NAFLD. The levels of BMI, uric acid, glycosylated hemoglobin, total cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol in the three groups were compared and analyzed. Results There were statistically significant differences in BMI, total cholesterol, triglyceride, uric acid，and glycosylated hemoglobin among the three groups（P＜0.05）.Among them, BMI and uric acid in groups B and C were significantly higher than that in group A. The total cholesterol and triglyceride in group C were significantly higher than those in groups A and B. HbA1c level was the highest in group B. There was no significant difference between the three groups in LDL cholesterol and HDL cholesterol （P＞0.05）. Conclusion BMI, total cholesterol, triglyceride, and uric acid are correlated with the degree of type 2 diabetes mellitus complicated with NAFLD, and risk factors should be screened and prevented as soon as possible.

基金项目：

作者简介：

参考文献：

参考文献

［1］ Alanna Weisman，Ghazal S，Fazil. Evolving trends in the epidemiology，

risk factors，and prevention of type 2 diabetes：a review［J］. Canadian

Journal of Cardiology，2018，34（5）：552-557.

［2］ Younossi ZM，Golabi P，de Avila L，et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes：a systematic review and meta-analysis［J］. J Hepatol，2019，7（4）：793-801.

［3］李治安.临床超声影像学［M］. 北京：人民卫生出版社，2003：924-926.

［4］邵幼林，范建高.非酒精性脂肪肝的流行现状及危害［J］. 中华肝脏病杂志，2019，27（1）：10-13.

［5］ Ballestri S，Zona S，Targher G，et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome： evidence from a systematic review and meta-analysis［J］. J Gastroenterol Hepatol，2016，31（5）：936-944.

［6］ Wild SH，Walker JJ，Morling JR，et a1. Cardiovascular disease，cancer，and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission［J］. Diabetes Care，2018，41（2）：341-347.

［7］张海伟，傅继华.非酒精性脂肪肝病与2型糖尿病关系的研究进展［J］. 药学研究，2019，37（10）：600-603.

［8］ Bouchi R，Takeuchi T，Akihisa M，et al. Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetes［J］. J Diabetes Investig J，2016，7（4）：607-614.

服务与反馈：

【文章下载】【加入收藏】